GrantedDecided 19 July 2007Cork County Council

Ballintaggart

Planning application 07/8150
DecisionConditional grant
Decided19 July 2007
Application typePERMISSION
Source documents1

Site

What is on file

0refusal reasons0conditions8nearby records

Proposed development

Application description published by Cork County Council.
Construction of Monoclonal Antibodies, Small Scale biotechnology facility comprising of three storey manufacturing building with penthouse plant room on third floor level, two storey administration/laboratory wing and warehouse wing, external utilities yard to west of facility, a detached station/guard house, internal ring road, upgrading of existing car park to provide 187 no. staff car parking spaces, provision for 14 no. visitor car parking spaces, landscaping, palisade fencing to site perimeter and decorative fence to South building facade,signage, sewage treatment unit and all associated site works and services

Application and appeal history

Structured appeal stages, outcomes and source documents currently tied to this application.

No indexed appeal history

No structured appeal case is tied to this application. This means no appeal is indexed, not that an appeal is impossible.

Decision details

Core application dates and identifiers from the public planning record.

Planning analysis

Refusal reasons and planning conditions extracted from the public decision file.

Refusal reasons

No refusal reason on record

Documents are indexed. Reason extraction for Cork has not started yet.

Conditions

No conditions

No conditions are on record for this application yet.

Planning a project near Ballintaggart?

Get a site risk brief with the local decision pattern and up to 80 detailed nearby comparables (40 refusals and 40 grants), including extracted reasons and source links. €29 incl. VAT, PDF by email.

Source documents

Original council portal records and source PDFs where available.

Nearby precedent

Similar nearby applications linked to this planning decision.
Get up to 80 detailed nearby comparables in a site risk brief →